WD Rutherford LLC Sells 260 Shares of Intuitive Surgical, Inc. $ISRG

WD Rutherford LLC lessened its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.1% during the second quarter, HoldingsChannel.com reports. The fund owned 8,120 shares of the medical equipment provider’s stock after selling 260 shares during the period. Intuitive Surgical makes up approximately 2.0% of WD Rutherford LLC’s holdings, making the stock its 18th largest holding. WD Rutherford LLC’s holdings in Intuitive Surgical were worth $4,412,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently made changes to their positions in the stock. Aaron Wealth Advisors LLC boosted its stake in shares of Intuitive Surgical by 0.8% in the 2nd quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock valued at $1,374,000 after purchasing an additional 19 shares in the last quarter. Crown Wealth Group LLC boosted its stake in shares of Intuitive Surgical by 4.8% in the 1st quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider’s stock valued at $218,000 after purchasing an additional 20 shares in the last quarter. FSM Wealth Advisors LLC boosted its stake in shares of Intuitive Surgical by 3.8% in the 1st quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider’s stock valued at $270,000 after purchasing an additional 20 shares in the last quarter. CFO4Life Group LLC boosted its stake in shares of Intuitive Surgical by 4.8% in the 1st quarter. CFO4Life Group LLC now owns 436 shares of the medical equipment provider’s stock valued at $216,000 after purchasing an additional 20 shares in the last quarter. Finally, J. W. Coons Advisors LLC boosted its stake in shares of Intuitive Surgical by 1.4% in the 1st quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider’s stock valued at $741,000 after purchasing an additional 20 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

ISRG stock opened at $441.12 on Friday. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The company has a market cap of $158.13 billion, a P/E ratio of 61.52, a PEG ratio of 4.62 and a beta of 1.61. The firm has a 50-day moving average of $469.43 and a 200 day moving average of $501.49.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same period in the prior year, the firm earned $1.78 earnings per share. Intuitive Surgical’s revenue was up 21.4% on a year-over-year basis. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on ISRG. UBS Group upped their price objective on shares of Intuitive Surgical from $547.00 to $585.00 and gave the company a “neutral” rating in a research note on Wednesday, July 23rd. Wall Street Zen cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Friday. Zacks Research cut shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 20th. BTIG Research increased their price target on shares of Intuitive Surgical from $566.00 to $571.00 and gave the company a “buy” rating in a research report on Wednesday, July 23rd. Finally, Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Thirteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $595.95.

Insider Buying and Selling

In related news, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the transaction, the insider directly owned 19,827 shares of the company’s stock, valued at $9,368,059.23. This represents a 59.69% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Amy L. Ladd sold 336 shares of the stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the transaction, the director owned 1,074 shares of the company’s stock, valued at approximately $504,898.14. The trade was a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 45,224 shares of company stock valued at $21,716,492 over the last three months. Corporate insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.